Abstract
The theft of medicines is a significant component of the illicit trade in pharmaceutical products. Besides small-scale thefts committed for personal usage, organised criminal networks are increasingly targeting high-priced medical products, either to reintroduce them into the legal supply chain or sell them on the black market. This crime has considerable implications that extend beyond the value of the stolen goods, including harmful impacts on citizens' health, legitimate companies, and national health systems. However, knowledge on organised theft of medicines remains limited. This paper employs a crime script analysis approach, based on interviews with relevant stakeholders and case studies retrieved across European countries, to examine the most common modi operandi in the organised theft of medicines and medical devices. Potential policy implications are also discussed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10610-023-09546-w.